Workflow
Mawson Infrastructure Group Inc. Announces 1-for-20 Reverse Stock Split
Globenewswire· 2025-11-19 13:40
MIDLAND, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a technology company that provides digital infrastructure for artificial intelligence (“AI”), high-performance computing (“HPC”) and digital assets, today announced that the Company’s Board of Directors has approved the implementation of a reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock ...
Form 8.3 Bluefield Solar Income Fund Ltd.
Globenewswire· 2025-11-19 13:39
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose re ...
FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Globenewswire· 2025-11-19 13:36
HOUSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced it has entered into a definitive agreement for the issuance and sale to an existing shareholder of 3,540,000 shares of its common stock and pre-funded warrants to ...
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
Globenewswire· 2025-11-19 13:30
BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced the appointment of Dr. Inderjit Kaul, Chief Medical Officer of Draig Therapeutics, to the board of directors. Dr. Kaul will also serve as a consultant to the Company for the future clinical development of roluperidone. Last month, the Company announced successfully raising ...
DTST Reports Q3 2025 Results Following Transformative CloudFirst Sale
Globenewswire· 2025-11-19 13:30
Transaction Unlocks Shareholder Value and Refocuses Company on High-Growth AI, Cybersecurity, and Infrastructure Markets Conference Call to be Held Today at 10:00 am ET MELVILLE, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (the “Company”), today provided a business update and reported financial results for the three months and nine months ended September 30, 2025. Chuck Piluso, Chairman and Chief Executive Officer of Data Storage Corporation, commented, “This quarter repr ...
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
Globenewswire· 2025-11-19 13:30
Call scheduled for today, Wednesday, November 19, 2025, at 5:00 pm ETLITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective diagnostic procedures and proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults and moderate to severe OSA in children), today announced it p ...
FST Corp. Revenue Up 47 Percent in Q3 2025; Improved Gross Margin and Bottom Line
Globenewswire· 2025-11-19 13:30
BOULDER, CO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- FST Corp. (Nasdaq: KBSX), a leading manufacturer and marketer of steel and graphite golf shafts and a provider of other golf-related services, today announced that, for the third quarter ended September 30, 2025, the Company had revenue of $12,554,939, a 47 percent improvement compared with revenue of $8,527,875 for the third quarter ended September 30, 2024. This increase was primarily the result of wider wholesale market acceptance of KBS graphite shafts and ...
Jet.AI Announces AI Infrastructure Acquisition Corp's Participation in Today's NYSE Opening Bell Ceremony
Globenewswire· 2025-11-19 13:30
LAS VEGAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Jet.AI Inc. ("Jet.AI" or the "Company") (Nasdaq: JTAI), an emerging leader in high-performance GPU infrastructure and AI cloud services, announced that AI Infrastructure Acquisition Corp (NYSE: AIIAU) will be ringing the New York Stock Exchange (“NYSE”) Opening Bell today. The bell ringing will be broadcasted live on the NYSE website here: https://www.nyse.com/bell. AI Infrastructure Acquisition Corp is a blank check company pursuing a business combination with h ...
TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies
Globenewswire· 2025-11-19 13:30
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number 27 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 31st year. The Company’s growth between fiscal years 2021 to 2024 was fueled by BRIUMVI® revenues, which was approved in the United States by the Food and Drug Administration (FDA) to treat adult indiv ...
Nanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S. Rollout of AI Solutions
Globenewswire· 2025-11-19 13:30
PETACH TIKVA, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that the parties have agreed on the terms and conditions pursuant to which Nanox will acquire VasoHealthcare IT Inc. (“VHC IT”) from Vaso Corporation (“Vaso”) (OTCQX: VASO), subject to certain conditions. This transaction is intended to accelerate deployment of Nanox’s AI solutions across U.S. healthcare facilities and is expec ...